Sandra S. Park, JD, lead counsel in the lawsuit challenging gene patents held by Myriad Genetics, discusses the case, and Federico Monzon, MD, director of Molecular Pathology, Cancer Genetics Laboratory, Baylor University, discusses its impacts.
Read MoreThe meeting will be a forum to learn more about new diagnostic tools and techniques. Hotspot testing will be compared to comprehensive genome profiling, emerging technologies will be explored, including molecular test development.
Read More
This kit, which had received the CE mark but is not yet FDA approved for IVD use in the United States, is the first sequence-based infectious disease diagnostic kit on the market, according to the company.
Read More
From a cart to store supplies—to lab automation, we have you covered.
Read More
Advances in anatomic and digital pathology are enabling medical professionals to make more accurate diagnoses than ever before.
Read More